PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VanEck Vectors Pharmaceutical ETF (PPH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISIN

US92189F6925

CUSIP

92189F692

Issuer

VanEck

Inception Date

Dec 20, 2011

Region

Developed Markets (Broad)

Leveraged

1x

Index Tracked

MVIS US Listed Pharmaceutical 25 Index

Asset Class

Equity

Asset Class Size

Multi-Cap

Asset Class Style

Blend

Expense Ratio

PPH features an expense ratio of 0.36%, falling within the medium range.


Expense ratio chart for PPH: current value at 0.36% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.36%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
PPH vs. IHE PPH vs. XLV PPH vs. XPH PPH vs. PJP PPH vs. VIRS PPH vs. VHT PPH vs. VOO PPH vs. IHI PPH vs. FPHAX PPH vs. VDC
Popular comparisons:
PPH vs. IHE PPH vs. XLV PPH vs. XPH PPH vs. PJP PPH vs. VIRS PPH vs. VHT PPH vs. VOO PPH vs. IHI PPH vs. FPHAX PPH vs. VDC

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in VanEck Vectors Pharmaceutical ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-4.84%
9.66%
PPH (VanEck Vectors Pharmaceutical ETF)
Benchmark (^GSPC)

Returns By Period

VanEck Vectors Pharmaceutical ETF had a return of 9.45% year-to-date (YTD) and 10.68% in the last 12 months. Over the past 10 years, VanEck Vectors Pharmaceutical ETF had an annualized return of 5.01%, while the S&P 500 had an annualized return of 11.11%, indicating that VanEck Vectors Pharmaceutical ETF did not perform as well as the benchmark.


PPH

YTD

9.45%

1M

-0.88%

6M

-4.84%

1Y

10.68%

5Y*

8.27%

10Y*

5.01%

^GSPC (Benchmark)

YTD

25.25%

1M

0.08%

6M

9.66%

1Y

25.65%

5Y*

13.17%

10Y*

11.11%

Monthly Returns

The table below presents the monthly returns of PPH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20244.83%4.10%2.14%-2.88%3.31%1.13%2.15%6.82%-4.43%-3.50%-1.28%9.45%
20230.77%-3.43%2.62%2.47%-4.08%4.12%2.60%1.84%-2.49%-5.29%4.25%4.03%6.95%
2022-1.44%-0.18%5.35%-2.23%2.17%-3.02%0.40%-8.01%-4.95%8.78%5.74%1.23%2.64%
20212.51%-0.90%2.21%1.24%3.78%1.26%2.87%1.58%-4.23%3.69%-4.95%8.12%17.79%
2020-0.14%-7.86%-7.89%12.04%4.52%-1.64%1.63%2.40%-3.66%-4.86%10.41%2.61%5.48%
20196.95%3.58%0.03%-3.50%-5.98%7.18%-1.61%-1.78%0.99%4.55%4.83%3.56%19.39%
20183.68%-5.95%-1.73%0.48%2.40%1.64%5.38%2.76%1.15%-5.73%3.72%-12.28%-5.87%
2017-0.36%6.29%-0.85%0.96%3.89%2.98%-1.30%-4.07%3.83%-4.00%3.98%3.52%15.23%
2016-7.78%-4.68%0.16%2.40%1.08%-0.42%6.06%-4.85%-2.40%-9.49%0.06%1.57%-17.78%
20151.68%5.89%1.50%1.45%3.11%-3.02%5.27%-8.30%-7.44%3.50%-0.25%1.23%3.53%
20141.92%9.96%-1.93%3.65%0.17%3.07%-1.93%2.62%2.24%0.01%4.50%-2.59%23.19%
20137.24%0.40%5.45%3.70%0.06%-1.90%5.70%-2.72%2.93%4.40%4.79%2.26%36.83%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PPH is 48, indicating average performance compared to other ETFs on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of PPH is 4848
Overall Rank
The Sharpe Ratio Rank of PPH is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of PPH is 5252
Sortino Ratio Rank
The Omega Ratio Rank of PPH is 5252
Omega Ratio Rank
The Calmar Ratio Rank of PPH is 4747
Calmar Ratio Rank
The Martin Ratio Rank of PPH is 3636
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for PPH, currently valued at 1.02, compared to the broader market0.002.004.001.022.07
The chart of Sortino ratio for PPH, currently valued at 1.47, compared to the broader market-2.000.002.004.006.008.0010.001.472.76
The chart of Omega ratio for PPH, currently valued at 1.18, compared to the broader market0.501.001.502.002.503.001.181.39
The chart of Calmar ratio for PPH, currently valued at 0.87, compared to the broader market0.005.0010.0015.000.873.05
The chart of Martin ratio for PPH, currently valued at 2.42, compared to the broader market0.0020.0040.0060.0080.00100.002.4213.27
PPH
^GSPC

The current VanEck Vectors Pharmaceutical ETF Sharpe ratio is 1.02. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of VanEck Vectors Pharmaceutical ETF with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.001.502.002.503.003.50JulyAugustSeptemberOctoberNovemberDecember
1.02
2.07
PPH (VanEck Vectors Pharmaceutical ETF)
Benchmark (^GSPC)

Dividends

Dividend History

VanEck Vectors Pharmaceutical ETF provided a 1.83% dividend yield over the last twelve months, with an annual payout of $1.61 per share.


1.60%1.80%2.00%2.20%2.40%$0.00$0.50$1.00$1.5020132014201520162017201820192020202120222023
Dividends
Dividend Yield
PeriodTTM20232022202120202019201820172016201520142013
Dividend$1.61$1.70$1.20$1.25$1.10$1.14$1.08$1.14$1.27$1.26$1.10$1.08

Dividend yield

1.83%2.09%1.55%1.62%1.66%1.77%1.97%1.92%2.43%1.93%1.71%2.03%

Monthly Dividends

The table displays the monthly dividend distributions for VanEck Vectors Pharmaceutical ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$0.53$0.00$0.00$0.36$0.00$0.00$0.41$0.00$0.00$1.30
2023$0.00$0.00$0.00$0.66$0.00$0.00$0.39$0.00$0.00$0.34$0.00$0.31$1.70
2022$0.00$0.00$0.00$0.44$0.00$0.00$0.25$0.00$0.00$0.27$0.00$0.24$1.20
2021$0.00$0.00$0.00$0.35$0.00$0.00$0.29$0.00$0.00$0.35$0.00$0.27$1.25
2020$0.00$0.00$0.00$0.34$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.27$1.10
2019$0.00$0.00$0.00$0.39$0.00$0.00$0.28$0.00$0.00$0.29$0.00$0.17$1.14
2018$0.00$0.00$0.00$0.39$0.00$0.00$0.25$0.00$0.00$0.24$0.00$0.20$1.08
2017$0.00$0.00$0.00$0.47$0.00$0.00$0.30$0.00$0.00$0.22$0.00$0.15$1.14
2016$0.00$0.00$0.00$0.63$0.00$0.00$0.29$0.00$0.00$0.22$0.00$0.15$1.27
2015$0.00$0.00$0.00$0.50$0.00$0.00$0.28$0.00$0.00$0.28$0.00$0.20$1.26
2014$0.00$0.00$0.00$0.40$0.00$0.00$0.26$0.00$0.00$0.20$0.00$0.24$1.10
2013$0.04$0.00$0.00$0.39$0.00$0.00$0.27$0.00$0.00$0.21$0.00$0.18$1.08

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-11.32%
-1.91%
PPH (VanEck Vectors Pharmaceutical ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the VanEck Vectors Pharmaceutical ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the VanEck Vectors Pharmaceutical ETF was 46.49%, occurring on Jul 23, 2002. Recovery took 2420 trading sessions.

The current VanEck Vectors Pharmaceutical ETF drawdown is 11.32%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-46.49%Dec 29, 2000389Jul 23, 20022420Mar 1, 20122809
-30.17%Aug 6, 20151165Mar 23, 2020200Jan 6, 20211365
-21.14%Feb 9, 200019Mar 7, 200020Apr 4, 200039
-20.26%Apr 11, 2022117Sep 27, 2022216Aug 8, 2023333
-15.07%Jul 12, 200040Sep 6, 200033Oct 23, 200073

Volatility

Volatility Chart

The current VanEck Vectors Pharmaceutical ETF volatility is 3.78%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JulyAugustSeptemberOctoberNovemberDecember
3.78%
3.82%
PPH (VanEck Vectors Pharmaceutical ETF)
Benchmark (^GSPC)
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab